List of largest biotechnology companies

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]

Independent biotechnology companies

Rank Change Company Country Highest Market Cap ever (historical)(USD billions) Market Cap in Q1 2016 (USD billions)[3][4] Market Cap in 2015 (USD billions)[5] Market Cap in 2014 (USD billions)[6] Market Cap in 2013 (USD billions)
1SteadyJohnson & Johnson United States306.4
September 2014
298.9 284.2 277.8 258.3
2SteadyRoche  Switzerland263.6
February 2014
208.8 234.7 258.5 240.3
3SteadyNovartis  Switzerland275.2
July 2015
195.2 206.1 229.8 195.0
4SteadyPfizer United States310.5
July 2000
186.4 199.3 205.4 196.0
5IncreaseMerck & Co. United States178.9
January 2015
148.0 147.6 166.9 146.5
6SteadyGilead Sciences United States179.6
June 2013
124.9 145.8 109.078.4
7IncreaseAmgen United States130.6
December 2014
113.3 122.5 93.178.7
8DecreaseNovo Nordisk Denmark153.8
June 2015
112.0 153.9 125.4 19.6
9IncreaseSanofi France151.3
September 2014
106.6 111.8 138.1 142.0
10SteadyBristol-Myers Squibb United States115.3
May 2015
105.4 114.8 97.6 87.2
11IncreaseGlaxoSmithKline United Kingdom174.9
May 2006
100.2 97.6 128.9 129.6
12DecreaseBayer Germany129
March 2015
97.1 103.2 113.2 117.4
13IncreaseAbbVie United States112.2
June 2015
92.5 96.8 104.1 83.8
14DecreaseEli Lilly & Co United States122.6
August 2000
79.7 93.4 76.6 57.0
15IncreaseCelgene United States102.9
March 2015
77.6 94.1 89.5 69.2
16IncreaseAstraZeneca United Kingdom102.9
October 2006
70.9 85.8 88.9 74.6
17IncreaseAbbott Laboratories United States74.8
July 2015
62.0 67.0 67.9 59.3
18SteadyBiogen Idec United States111.7
March 2015
56.6 68.3 79.7 66.1
19IncreaseTeva Pharmaceutical Israel58.9
April 2010
54.1 55.9 49.0 37.8
20IncreaseStryker Corporation United States40.2
March 2016
40.2 34.7 35.7 28.4
21DecreaseRegeneron Pharmaceuticals Inc United States56.5
December 2015
37.3 56.5 42.0 27.4
22IncreaseShire Pharmaceuticals Ireland52.4
October 2014
34.0 41.0 42.4 28.1
23DecreaseAlexion Pharmaceuticals United States43.1
June 2015
31.6 43.0 36.8 26.2
24IncreaseBaxalta Inc United States27.5
April 2015
27.5 27.5 21.2 16.1
25SteadyMylan United States37.2
April 2015
22.826.6 21.2 16.1

Milestones

  • Q1 2016
    • Valeant exits the top-25 list with a decrease in market cap of $25 billion.
    • Allergan, plc exits the list due to its merger with Pfizer.
    • Stryker & Baxalta enter the top-25

References

  1. "The Convention on Biological Diversity (Article 2. Use of Terms)." United Nations. 1992. Retrieved on February 6, 2008.
  2. Carlo Alberto Oppici, Filippo Giancarlo Martinelli. "BioDirecta". Retrieved 22 March 2015.
  3. "Healthcare – Google Finance".
  4. "Healthcare – Google Finance".
  5. "The World’s Biggest Public Companies". Forbes.
  6. "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista.

External links


This article is issued from Wikipedia - version of the Thursday, March 31, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.